Skip to main content
. 2024 Mar 14;15:1355198. doi: 10.3389/fimmu.2024.1355198

Table 2.

Clinical response after completion of radiotherapy.

CCRT alone (n=58) CCRT+ICI (n=43) P
Complete response 0.037
 no 57 (98.3%) 38 (88.4%)
 yes 1 (1.7%) 5 (11.6%)
Partial response 0.766
 no 32 (55.2%) 25 (58.1%)
 yes 26 (44.8%) 18 (41.9%)
Stable disease 0.097
 no 31 (53.4%) 30 (69.8%)
 yes 27 (46.6%) 13 (30.2%)
Progressive disease 0.999
 no 58 (100.0%) 43 (100.0%)
 yes 0 (0.0%) 0 (0.0%)
Unknown 0.134
 no 54 (93.1%) 36 (83.7%)
 yes 4 (6.9%) 7 (16.3%)
Objective response rate 0.491
 no 31 (53.4%) 20 (46.5%)
 yes 27 (46.6%) 23 (53.5%)
Disease control rate 0.134
 no 4 (6.9%) 7 (16.3%)
 yes 54 (93.1%) 36 (83.7%)

CCRT, concurrent chemoradiotherapy; ICI, immune checkpoint inhibitors.